Growth Metrics

Usana Health Sciences (USNA) Income from Continuing Operations (2016 - 2026)

Usana Health Sciences has reported Income from Continuing Operations over the past 17 years, most recently at 6959000.0 for Q2 2026.

  • Quarterly Income from Continuing Operations fell 25.09% to 6959000.0 in Q2 2026 from the year-ago period, while the trailing twelve-month figure was 9146000.0 through Apr 2026, down 73.73% year-over-year, with the annual reading at 11477000.0 for FY2026, 72.71% down from the prior year.
  • Income from Continuing Operations was 6959000.0 for Q2 2026 at Usana Health Sciences, up from 1595000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 31470000.0 in Q1 2022 and troughed at 6662000.0 in Q3 2025.
  • The 5-year median for Income from Continuing Operations is 12071000.0 (2022), against an average of 12505777.78.
  • Year-over-year, Income from Continuing Operations skyrocketed 31.04% in 2023 and then plummeted 162.81% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 12795000.0 in 2022, then surged by 31.04% to 16766000.0 in 2023, then crashed by 73.26% to 4484000.0 in 2024, then plummeted by 248.57% to 6662000.0 in 2025, then soared by 204.46% to 6959000.0 in 2026.
  • Per Business Quant, the three most recent readings for USNA's Income from Continuing Operations are 6959000.0 (Q2 2026), 1595000.0 (Q1 2026), and 6662000.0 (Q3 2025).